Aker BioMarine AS
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKBM.OL research report →
Companywww.akerbiomarine.com
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application.
- CEO
- Matts Johansen
- IPO
- 2020
- Employees
- 249
- HQ
- Lysaker, NO
Price Chart
Valuation
- Market Cap
- $9.32B
- P/E
- -45.03
- P/S
- 4.47
- P/B
- 7.14
- EV/EBITDA
- 22.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 39.97%
- Op Margin
- 41.27%
- Net Margin
- -9.94%
- ROE
- -15.31%
- ROIC
- 27.29%
Growth & Income
- Revenue
- $224.51M · 12.82%
- Net Income
- $-23,469,677 · -113.02%
- EPS
- $-0.27 · -68.75%
- Op Income
- $21.10M
- FCF YoY
- 66.35%
Performance & Tape
- 52W High
- $118.00
- 52W Low
- $55.00
- 50D MA
- $104.78
- 200D MA
- $93.97
- Beta
- 0.27
- Avg Volume
- 17.43K
Get TickerSpark's AI analysis on AKBM.OL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AKBM.OL Coverage
We haven't published any research on AKBM.OL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AKBM.OL Report →